Halo Pharmaceutical Completes $14.6 Million in Financing
Thu, 04/23/2009 - 4:41am
Halo Pharmaceutical, hasannounced that it has completed $14.6 million in financing from The ProvidentBank to expand its operations. Headquartered in Whippany, Halo is a privately held full-service,specialty pharmaceutical company. Halo provides state-of-the-art contractmanufacturing, early stage formulation development and laboratory services tothe pharmaceutical and related industries. "Provident is a respected local bank that understands the New Jerseymarket and the needs of New Jersey's pharmaceutical companies. That's why wechose to go to them for financing," said Mohd Asif, Halo's Chief FinancialOfficer. "Provident understands that providing the kind of financing thatassists local companies helps keep jobs in the Garden State and even helpscreate jobs here in the future. We look forward to an ongoing closerelationship with them." "We are excited to be working with Halo," said Keith Stinchcomb, Providentvice president and team leader of middle market lending. "At Provident, wefocus on building strong relationships with our clients so we can best meettheir financial needs. We look forward to continuing to work with Halo as theygrow." Halo's Whippany facilities encompass more than 200,000 sq. ft. and includean array of capabilities.